PEHLIMED
ActiveSummary
PEHLIMED has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €440,915 and a net result of €191,793. Equity remains stable across the filed fiscal years (±1.2% per year). Its solvency ranks better than 31% of 19923 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability94▲+7
Solvency71▲+18
Growth78▲+20
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30,000 at 30 days acceptable
Liquidity ample (current ratio 1.8 against 1.35 in 2023; short-term debt: 52.9% and cash: 0.2% of total assets), but 54% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Growing equity
Reported equity is higher than in 2022 and did not fall compared with 2023. These amounts do not establish the cause of the change.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year €440,915
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
61 d late
2022
38 d late
2021
92 d late
2020
83 d late
2019
88 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 71 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€191,793▲ 47.0%
2023 · €130,450
Working capital
€406,530▲ 85.0%
2023 · €219,699
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result-€81,799€162,227-€114,045€192,289€235,510▲ 22.5%
Net result-€70,819below the sector's middle half€138,680above the sector's middle half-€139,229below the sector's middle half€130,450above the sector's middle half€191,793above the sector's middle half▲ 47.0%
Equity€355,449above the sector's middle half▼ 16.6%€494,129above the sector's middle half▲ 39.0%€118,672within the sector's middle half▼ 76.0%€249,123within the sector's middle half▲ 110%€440,915above the sector's middle half▲ 77.0%
Total assets€701,183above the sector's middle half▲ 12.2%€929,850above the sector's middle half▲ 32.6%€1.1mabove the sector's middle half▲ 14.8%€895,905above the sector's middle half▼ 16.1%€958,147above the sector's middle half▲ 6.9%
Debt€43,079▼ 68.9%€133,066▲ 209%€949,205▲ 613%€646,782▼ 31.9%€517,232▼ 20.0%
Working capital€641,525above the sector's middle half▲ 34.9%€799,124above the sector's middle half▲ 24.6%€98,165within the sector's middle half▼ 87.7%€219,699within the sector's middle half▲ 124%€406,530above the sector's middle half▲ 85.0%
Solvency50.7%within the sector's middle half▼ 17.5pp53.1%within the sector's middle half▲ 2.4pp11.1%below the sector's middle half▼ 42.0pp27.8%below the sector's middle half▲ 16.7pp46.0%within the sector's middle half▲ 18.2pp
Current ratio15.91above the sector's middle half▲ 11.488.89above the sector's middle half▼ 7.021.11below the sector's middle half▼ 7.791.35below the sector's middle half▲ 0.241.80within the sector's middle half▲ 0.45
Return on assets (ROA)-10.1%below the sector's middle half▼ 20.1pp14.9%within the sector's middle half▲ 25.0pp-13.0%below the sector's middle half▼ 28.0pp14.6%within the sector's middle half▲ 27.6pp20.0%within the sector's middle half▲ 5.5pp
Staff (FTE)1.22.6▲ 117%4▲ 53.8%5.5▲ 37.5%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 22% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €958,147
Fixed assets
€44,486 ▼ 14.2%
Current assets
€913,661 ▲ 8.2%
Equity and liabilities €958,147
Equity
€440,915 ▲ 77.0%
Debt
€517,232 ▼ 20.0%
Debt's share of the balance-sheet total falls from 72.2% to 54.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€249,845▲
2023 · €207,708
Cash flow
€206,127▲
2023 · €145,869
Debt to equity
1.17▼
2023 · 2.60
ROE
43.5%▼
2023 · 52.4%
Interest coverage
75.42▲
2023 · 66.37
Debt ≤ 1 year
€507,132▼
2023 · €624,381
Debt > 1 year
€8,718▼
2023 · €21,019
Income taxes
€64,858▲
2023 · €58,712
Staff costs
€222,056▲
2023 · €124,078
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 34,679 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.6%
went bankrupt
3.8%
stopped otherwise
95%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 34,679 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €26,889 | €89,531 | €124,078 | €222,056 | ▲ 79.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €8,145 | €9,006 | €10,793 | €15,419 | €14,335 | ▼ 7.0% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | -€302,655 | - | - | - |
| Other operating charges640/8 | - | €1,769 | €237,112 | €31,612 | - | - |
| Non-recurring operating charges66A | - | - | €302,655 | - | - | - |
| Gross operating margin9900 | €188,508 | €199,891 | €223,391 | €363,397 | €471,901 | ▲ 29.9% |
| Operating profit (loss)9901 | -€81,799 | €162,227 | -€114,045 | €192,289 | €235,510 | ▲ 22.5% |
| Financial income75/76B | - | €21,436 | €25,905 | €3 | €24,453 | ▲ 778,664% |
| Recurring financial income75 | €17,223 | €21,436 | €25,905 | €3 | €24,453 | ▲ 778,664% |
| Financial charges65/66B | - | €4,070 | €19,496 | €3,129 | €3,313 | ▲ 5.9% |
| Recurring financial charges65 | €3,859 | €4,070 | €19,496 | €3,129 | €3,313 | ▲ 5.9% |
| Profit (loss) for the period before taxes9903 | -€68,435 | €179,593 | -€107,636 | €189,163 | €256,651 | ▲ 35.7% |
| Income taxes67/77 | €2,384 | €40,913 | €31,593 | €58,712 | €64,858 | ▲ 10.5% |
| Profit (loss) for the period9904 | -€70,819 | €138,680 | -€139,229 | €130,450 | €191,793 | ▲ 47.0% |
| Profit (loss) for the period to be appropriated9905 | -€70,819 | €138,680 | -€139,229 | €130,450 | €191,793 | ▲ 47.0% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €701,183 | €929,850 | €1.1m | €895,905 | €958,147 | ▲ 6.9% |
| Fixed assets21/28 | €16,644 | €29,500 | €54,298 | €51,825 | €44,486 | ▼ 14.2% |
| Tangible fixed assets22/27 | €16,619 | €29,475 | €54,273 | €44,300 | €36,961 | ▼ 16.6% |
| Plant, machinery and equipment23 | - | €7,044 | €5,964 | €1,585 | €3,040 | ▲ 91.8% |
| Furniture and vehicles24 | - | €6,237 | €15,457 | €12,308 | €11,607 | ▼ 5.7% |
| Leasing and similar rights25 | - | - | €13,010 | €9,942 | €6,874 | ▼ 30.9% |
| Other tangible fixed assets26 | - | €16,194 | €19,842 | €20,464 | €15,441 | ▼ 24.5% |
| Financial fixed assets28 | €25 | €25 | €25 | €7,525 | €7,525 | = |
| Current assets29/58 | €684,539 | €900,350 | €1.0m | €844,080 | €913,661 | ▲ 8.2% |
| Amounts receivable after more than one year29 | - | €845,188 | €960,030 | €838,036 | €861,836 | ▲ 2.8% |
| Other amounts receivable291 | - | €845,188 | €960,030 | €838,036 | €861,836 | ▲ 2.8% |
| Amounts receivable within one year40/41 | - | €22,749 | €2,432 | €2,432 | €46,201 | ▲ 1,799% |
| Trade receivables40 | - | €22,749 | €2,432 | €2,432 | €2,432 | = |
| Other amounts receivable41 | - | - | - | - | €43,769 | - |
| Cash at bank and in hand54/58 | €6,107 | €1,013 | €6,820 | €211 | €2,392 | ▲ 1,034% |
| Deferred charges and accrued income490/1 | - | €31,400 | €44,297 | €3,401 | €3,232 | ▼ 5.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €701,183 | €929,850 | €1.1m | €895,905 | €958,147 | ▲ 6.9% |
| Equity10/15 | €355,449 | €494,129 | €118,672 | €249,123 | €440,915 | ▲ 77.0% |
| Contributions10/11 | - | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Reserves13 | €413,729 | €481,729 | €245,501 | €245,501 | €245,501 | = |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Distributable reserves133 | - | €479,869 | €243,641 | €243,641 | €243,641 | = |
| Profit (loss) carried forward14 | -€70,680 | - | -€139,229 | -€8,779 | €183,014 | ▲ 2,185% |
| Provisions and deferred taxes16 | €302,655 | €302,655 | - | - | - | - |
| Provisions for liabilities and charges160/5 | - | €302,655 | - | - | - | - |
| Other liabilities and charges164/5 | - | €302,655 | - | - | - | - |
| Amounts payable17/49 | €43,079 | €133,066 | €949,205 | €646,782 | €517,232 | ▼ 20.0% |
| Amounts payable after more than one year17 | - | €31,840 | €33,249 | €21,019 | €8,718 | ▼ 58.5% |
| Financial debts170/4 | - | €31,840 | €33,249 | €21,019 | €8,718 | ▼ 58.5% |
| Amounts payable within one year42/48 | €43,014 | €101,226 | €915,414 | €624,381 | €507,132 | ▼ 18.8% |
| Current portion of amounts payable after more than one year42 | - | €8,421 | €12,547 | €12,230 | €12,301 | ▲ 0.6% |
| Financial debts43 | - | - | - | €4,139 | - | - |
| Credit institutions430/8 | - | - | - | €4,139 | - | - |
| Trade debts44 | €3,167 | €46,406 | €63,820 | €43,275 | €71,972 | ▲ 66.3% |
| Suppliers440/4 | - | €46,406 | €63,820 | €43,275 | €71,972 | ▲ 66.3% |
| Taxes, remuneration and social security45 | - | €46,399 | €99,688 | €110,977 | €192,697 | ▲ 73.6% |
| Taxes450/3 | - | €43,407 | €80,243 | €89,215 | €163,238 | ▲ 83.0% |
| Remuneration and social security454/9 | - | €2,992 | €19,445 | €21,762 | €29,459 | ▲ 35.4% |
| Other amounts payable47/48 | - | - | €739,359 | €453,761 | €230,161 | ▼ 49.3% |
| Accrued charges and deferred income492/3 | - | - | €542 | €1,383 | €1,383 | = |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€70,819 | €138,680 | -€139,229 | €130,450 | €191,793 | ▲ 47.0% |
| + Depreciation and write-downs630 | €8,145 | €9,006 | €10,793 | €15,419 | €14,335 | ▼ 7.0% |
| Operating cash flow (approximation) | -€62,674 | €147,686 | -€128,436 | €145,869 | €206,127 | ▲ 41.3% |
| Investment in fixed assets (approximation) | - | -€21,862 | -€35,591 | -€12,946 | -€6,996 | ▲ 46.0% |
| Change in cash | - | -€5,094 | €5,807 | -€6,609 | €2,181 | ▲ 133% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
31-12
Financial
Highest result since 2018net €191,793 ▲47%
Operating result €235,510, net result €191,793, both a record.
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 61 days late
2023
31-12
Financial
Back to profitnet €130,450
Net result €130,450 after one loss-making year.
31-12
Financial
Equity above €200,000Eq €249,123 ▲110%
Equity rises from €118,672 to €249,123.
07-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 38 days late
2022
31-12
Financial
Weakest financial yearnet -€139,229
Net result drops to -€139,229, the lowest in the series; recovery starts the following year.
31-10
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 92 days late
2021
31-12
Financial
Back to profitnet €138,680
Net result €138,680 after one loss-making year.
22-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 83 days late
2020
31-12
Financial
Liquidity quadruplescurrent ratio 15.91
Current ratio from 4.43 to 15.91; short-term debt falls from €138,545 to €43,014.
27-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 88 days late
Show earlier events
2019
17-09
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 48 days late
2018
31-10
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 92 days late
28-02
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 212 days late
2016
21-12
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 143 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 2 establishment units since 2012
Ground area
573 m²
Building footprint
456 m²
Volume, LiDAR
4,021 m³
2 parcels, Brussels · tallest building 17.7 m, ±4 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
2 establishment units
PEHLIMED
since 20122.214.391.818
Bergense Steenweg 1105, 1070 Anderlecht
since 20262.387.315.401
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21308H0673/00V002 | Brussels | 327 m² | 1 · 326 m² | 17.7 m · 2 fl. |
| 21306D0339/00E004 | Brussels | 247 m² | 1 · 131 m² | 15.9 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dokter Marc PHILIPPE - Heelkunde
BE 0823.822.681
Brugge · Eq €440,857
DOKTERSPRAKTIJK BERT LEYSEN
BE 0733.816.381
Ranst · Eq €440,483
Medical Science
BE 0458.268.580
Ukkel · Eq €441,725
DR SIEGFRIED GEENS , HUISARTS
BE 0896.552.291
Sint-Pieters-Leeuw · Eq €441,839
Dr. Patrick Impens
BE 0811.515.460
Gent · Eq €439,858
Of 9,130 companies in sector 86210 we hold annual accounts for 6,336. 4,990 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded16-11-2012
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Contact
E-mail
Mucahit@pehlimed.beAnderlecht
Phone
0486296266Anderlecht
Phone
02/521.14.85Anderlecht
E-invoicing
Reachable via Peppol
Peppol ID
0208:0500843464
Also
9925:BE0500843464
Registered
03-09-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.